Can Medicare Cover Obesity Drugs Without Congressional Action? Industry Builds Its Case
Pfizer-commissioned report says CMS can reinterpret existing law to permit coverage of new anti-obesity medicines in Medicare Part D. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
